Type II estrogen binding site agonist: Synthesis and biological evaluation of the enantiomers of methyl-para-hydroxyphenyllactate (MeHPLA)

Chirality

Volumn 15, Issue 8, 2003, Pages 674-679

  Pretlow, Lester ^a   Williams, Roy ^b   Elliott, Mark ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b OLD DOMINION UNIVERSITY   (United States)

Author keywords

Diastereomers; Methylation; Racemic; Reduction

Indexed keywords

ATROLACTIC ACID; ESTROGEN; METHYL 4 HYDROXYPHENYLLACTATE; UNCLASSIFIED DRUG;

AGONIST; ARTICLE; BINDING AFFINITY; BREAST CANCER; CELL GROWTH; CELL PROLIFERATION; DRUG ACTIVITY; DRUG SYNTHESIS; ENANTIOMER; ESTROGEN BINDING; FEMALE; HUMAN; HUMAN CELL; METHYLATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CATALYSIS; CELL DIVISION; COLONIC NEOPLASMS; FEMALE; HUMANS; LACTATES; RATS; RECEPTORS, ESTROGEN; STEREOISOMERISM; TUMOR CELLS, CULTURED;

EID: 0141566985     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/chir.10283     Document Type: Article

References (20)

1. Upchurch S, Hardin JW, Peck EJ, Clark JH. Heterogeneity of estrogen receptors in the cytosol and nuclear fractions of rat uterus. Biochem Biophys Res Commun 1983;81:1-7.
2. Barnes S, Peterson T. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 1995;208:103-108.
3. Makela S, Poutanen M, Lehtimaki J, Lostian M-L, Santii R, Vihko R. Estrogen-specific 17 beta-hydroxysteroid oxidoreductase type 1. Proc Soc Exp Biol Med 1995;208:51-59.
4. Markaverich B, Gregory RR, Alejandro M-A, Clark JH, Johnson JA, Middleditch BS. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-II binding sites. J Biol Chem 1988; 263:7202-7210.
5. Karoum F. On the origin of central and peripheral para-hydroxyphenylacetic acid in rats: a comparison with metabolites of biogenic amines other than para-tyramine. Biogenic Amines 1985;2:269-282.
6. Griffith L, Smith G. Metabolism of apigenin and related compounds in rat: metabolite formation in vivo and by the intestinal microflora in vitro. Biochem J 1972;128:901-911.
7. Markaverich B, Roberts RR, Finney RW, Clark JH. Preliminary characterization of an endogenous inhibitor of [3H] estradiol binding in rat uterine nuclei. J Biol Chem 1983;258:11663-11671.
8. Corey E, Bakshi R, Shibata S. Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications. J Am Chem Soc 1987;109:5551-5553.
9. Worthington manual. Worthington Biochemical Corp.; 2003.
10. Friedrich C, Morizot DC, Siciliano MJ, Ferrell RE. The reduction of aromatic alpha-keto acids by cytoplasmic malate dehydrogenase and lactate dehydrogenase. Biochem Genet 1987;25:657-668.
11. McMurry J. Organic chemistry, 2nd ed. Pacific Grove, CA: Brook/ Cole Publishing; 1988.
12. Hanai K, Kuwae A, Kawai S, Ono Y. Keto-enol tautomerization and vibrational spectra of phenylpyruvic acids. J Phys Chem 1989;93: 6013-6016.
13. Wendt S, Finkam M, Winer W, Ossig J, Raabe G, Zwingenberger K. Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues. Chirality 1996;8:390-396.
14. Wheatley D, Slater J, Love EM, Miseta A. Chirality differences in amino acid retention and release from the acid-extractable pool of cultured mammalian cells. Int J Biochem Cell Biol 1996;28:1349-1364.
15. Tsai M, O'Malley B. Molecular mechanisms of action of steroid/ thyroid receptor superfamily member. Annu Rev Biochem 1994;63: 451-486.
16. Coffey DS. Similarities of prostate and breast cancer: evolution, diet, and estrogens. Urology 2001;57:31-38.
17. Nakayama Y, Sakamoto H, Satoh K, Yamamoto T. Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system. Cancer Lett 2000; 161:63-71.
18. Huerta S, Arteaga JR, Irwin RW, Ikezoe T, Heber D, Koeffler HP. PC-SPES inhibits colon cancer growth in vitro and in vivo. Cancer Res 2002;62:5204-5209.
19. Arai N, Strom A, Rafter JJ, Gustafsson JA. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun 2000;270:425-431.
20. Fiorelli G, Picariello L, Martineti V, Tonelli F, Brandi ML. Functional estrogen receptor beta in colon cancer cells. Biochem Biophys Res Commun 1999;261:521-527.